| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial.
|
Trials
|
2013
|
0.81
|
|
2
|
An open-label study of effects of acupuncture on chronic fatigue syndrome and idiopathic chronic fatigue: study protocol for a randomized controlled trial.
|
Trials
|
2013
|
0.81
|
|
3
|
WIN-34B, a new herbal medicine, inhibits the inflammatory response by inactivating IκB-α phosphorylation and mitogen activated protein kinase pathways in fibroblast-like synoviocytes.
|
J Ethnopharmacol
|
2012
|
0.80
|
|
4
|
Gastroprotective and safety effects of WIN-34B, a novel treatment for osteoarthritis, compared to NSAIDs.
|
J Ethnopharmacol
|
2011
|
0.78
|
|
5
|
Standardized butanol fraction of WIN-34B suppresses cartilage destruction via inhibited production of matrix metalloproteinase and inflammatory mediator in osteoarthritis human cartilage explants culture and chondrocytes.
|
BMC Complement Altern Med
|
2012
|
0.78
|
|
6
|
Cartilage Protective and Chondrogenic Capacity of WIN-34B, a New Herbal Agent, in the Collagenase-Induced Osteoarthritis Rabbit Model and in Progenitor Cells from Subchondral Bone.
|
Evid Based Complement Alternat Med
|
2013
|
0.77
|
|
7
|
Bee venom acupuncture, NSAIDs or combined treatment for chronic neck pain: study protocol for a randomized, assessor-blind trial.
|
Trials
|
2014
|
0.77
|
|
8
|
Analgesic Effects of Diluted Bee Venom Acupuncture Mediated by δ-Opioid and α2-Adrenergic Receptors in Osteoarthritic Rats.
|
Altern Ther Health Med
|
2017
|
0.75
|